Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Grade Glioma: Glioblastoma (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00683761
What this trial is testing

131I-TM601 in Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeGBM+2 more
TransMolecular 64
Early research (Phase 1)Study completedNCT00074646
What this trial is testing

Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas

Who this might be right for
GlioblastomaMalignant Gliomas
Celgene Corporation 36
Testing effectiveness (Phase 2)Study completedNCT00687765
What this trial is testing

Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Glioblastoma
Sanofi 126
Early research (Phase 1)Study completedNCT00014521
What this trial is testing

Karenitecin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02590263
What this trial is testing

Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma Multiforme
AbbVie 53
Early research (Phase 1)Study completedNCT04826393
What this trial is testing

ASP8374 + Cemiplimab in Recurrent Glioma

Who this might be right for
GlioblastomaRecurrent Glioblastoma
Dana-Farber Cancer Institute 14
Testing effectiveness (Phase 2)Ended earlyNCT00243022
What this trial is testing

Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System TumorsCerebral Edema
Ali Altunkaya 12
Early research (Phase 1)Looking for participantsNCT03896568
What this trial is testing

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
IDH1 wt AlleleRecurrent Anaplastic AstrocytomaRecurrent Glioblastoma+2 more
M.D. Anderson Cancer Center 36
Early research (Phase 1)Looking for participantsNCT07464925
What this trial is testing

Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

Who this might be right for
Glioblastoma Multiforme of BrainGliomaGlioblastoma
Tetragon Biosciences Ltd 30
Early research (Phase 1)Study completedNCT02015819
What this trial is testing

Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
City of Hope Medical Center 16
Early research (Phase 1)Study completedNCT00884416
What this trial is testing

Sorafenib in Newly Diagnosed High Grade Glioma

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
University Hospital, Geneva 17
Early research (Phase 1)Active Not RecruitingNCT03389230
What this trial is testing

Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma

Who this might be right for
GlioblastomaMalignant GliomaRecurrent Glioma+2 more
City of Hope Medical Center 29
Early research (Phase 1)Ended earlyNCT02255461
What this trial is testing

Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors

Who this might be right for
Childhood Choroid Plexus TumorChildhood EpendymoblastomaChildhood Grade III Meningioma+16 more
Pediatric Brain Tumor Consortium 35
Early research (Phase 1)Study completedNCT01808820
What this trial is testing

Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+1 more
Macarena De La Fuente, MD 20
Not applicableActive Not RecruitingNCT05720078
What this trial is testing

UNIty-Based MR-Linac Guided Adaptive RadioThErapy for High GraDe Glioma-3 (UNITED-3)

Who this might be right for
Glioblastoma Multiforme, Adult
Sunnybrook Health Sciences Centre 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07751744
What this trial is testing

Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade Glioma

Who this might be right for
Brain Metastases From Solid TumorsLeptomeningeal DiseaseHigh Grade Glioma (HGG)+1 more
Jubilant Therapeutics Inc. 113
Testing effectiveness (Phase 2)Study completedNCT00404248
What this trial is testing

Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35
Testing effectiveness (Phase 2)Ended earlyNCT01478321
What this trial is testing

Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+2 more
Northwestern University 54
Early research (Phase 1)Study completedNCT02186509
What this trial is testing

Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+11 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 17
Testing effectiveness (Phase 2)Study completedNCT00337207
What this trial is testing

Bevacizumab in Treating Patients With Recurrent or Progressive Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 55
Next Page